Schedule 6 to the Principal Order is amended as follows:

(a) by inserting after item 6024 the following:

6024M.	Azadirachta indica (neem), including its extracts and derivatives except –
	(a) in preparations for human internal use; or
	(b) when included in Schedule 5 ; or
	(c) debitterised neem seed oil; or
	(d) in preparations for human dermal therapeutic use containing cold-pressed neem seed oil, when in a container fitted with a child-resistant closure and labelled with the statements:
	NOT TO BE TAKEN;
	KEEP OUT OF THE REACH OF CHILDREN;
	DO NOT USE IF PREGNANT OR LIKELY TO BECOME PREGNANT; or
	(e) in other preparations for dermal use containing 1% or less of cold-pressed neem seed oil.

(b) by omitting item 6038 ;

(c) by inserting after item 6085 the following:

6085M.

Chlothianidin.

(d) by omitting item 6139 ;

(e) by omitting item 6150 and substituting the following:

6150.

Diquat in preparations containing 20% or less of diquat.

(f) by omitting item 6273 and substituting the following:

6273.	Moxidectin for external use –
	(a) in preparations containing 2.5% or less of moxidectin when packed in single-dose tubes for the treatment of cats and dogs; or
	(b) in preparations containing 2% or less of moxidectin for the treatment of animals.

(g) by omitting item 6297 ;

(h) by omitting item 6316 ;

(i) by omitting item 6319 ;

(j) by omitting item 6337 ;

(k) by omitting item 6377 ;

(l) by inserting after paragraph (c) in item 6392 the following:

6392E.

Tetraconazole except when included in Schedule 5 .